Douglas S. Ingram - President & CEO, Director at Sarepta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
SRPT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Douglas S. Ingram - trading volume in the past year for Sarepta Therapeutics, Inc.

Holdings reported by Douglas S. Ingram for Sarepta Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 390K $31.4M $80.34 Nov 3, 2023 Direct

Transactions reported by Douglas S. Ingram for Sarepta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.